Objective: The effects of capsaicin on sensory neurons are mediated by its interaction with a specific membrane receptor and opening of a non-selective cation channel. In the rat heart, capsaicin-sensitive nerve endings are known to be activated by oxygen radicals. We investigated the possibility that free oxygen radicals stimulate sensory nerve endings by acting upon the capsaicin receptor. increased cardiac vagal and sympathetic afferent activity. Administration of capsazepine had no effect on the baseline activity of either vagal or sympathetic cardiac afferents, but it abolished the response of the afferent fibers to all doses of capsaicin, H O , and X q XO 2 2 tested. Capsazepine had no effect on afferent activation by bradykinin. Administration of another capsaicin receptor blocker, ruthenium Ž . red 780 mgrkg, i.v. , had similar effects. Conclusions: The results of these experiments indicate that blockade of capsaicin receptors inhibits activation of vagal and sympathetic cardiac afferent fibers by free oxygen radicals. The fact that capsazepine and ruthenium red did not affect the afferent response to bradykinin suggests that this effect of the blockers was specific for capsaicin receptors. The possible functional implications of this interaction are discussed. q
Introduction
Capsaicin, the pungent ingredient of Capsicum pepper, is a specific activator of nociceptive sensory neurons with w x C and A d fibers 1 . The effects of capsaicin on sensory neurons are mediated by its interaction with a specific membrane receptor and opening of a non-selective cation w x channel 2 . A specific antagonist of the capsaicin receptor, w x capsazepine, was recently developed 3 , and its effectiveness in antagonizing the various physiological effects of w x capsaicin has been demonstrated 4-6 . Another capsaicin antagonist, ruthenium red, was described as a 'functional w x capsaicin antagonist' 7 , because it does not interfere with w x the capsaicin-binding site of the receptor 8 , but blocks the w x capsaicin-activated ion channel 9,10 . However, the effect ) Corresponding author. Tel.: q1 402 5597167; fax: q1 402 5594438. of ruthenium red is selective since it attenuated capsaicin induced activation of nociceptors and release of sensory neuropeptides, but did not affect sensory neuron activation w x by other stimuli 10-12 . In previous experiments, we have demonstrated that capsaicin activates cardiac chemosensitive neurons with w x C-fiber vagal afferents 13,14 . These capsaicin-sensitive afferents could be activated by free oxygen radicals derived from hydrogen peroxide or xanthinerxanthine oxiw x dase mixture 13 or produced endogenously at reperfusion w x after prolonged ischemia 14 . Interestingly, free oxygen radicals stimulated only those vagal afferent fibers that were capsaicin-sensitive. Similarly, experiments performed w x by Huang et al. 15, 16 demonstrated that free oxygen radicals stimulate cardiac chemosensitive nerve endings ( )with sympathetic C-fiber afferents. These endings also are known to be capsaicin-sensitive. These data prompted us to hypothesize that free oxygen radicals stimulate sensory nerve endings by acting through the capsaicin receptor.
In the present study we investigated this possibility by documenting the effects of capsaicin and free oxygen radicals on cardiac capsaicin-sensitive vagal and sympathetic afferent fibers before and after blockade of capsaicin receptors with either capsazepine or ruthenium red. We also documented the effect of bradykinin on the afferent endings to assess the possibility that the capsaicin antagonists could have altered afferent responses to a mediator w x known to act independently of the capsaicin receptor 17 .
Methods

Ž
. Sprague-Dawley rats 250-320 g, males were anesthetized intraperitoneally with a mixture of 2% a-chlo-Ž . ralose and 25% urethane in saline 3 mlrkg . The lungs Ž were ventilated by a rat respirator 60 breathsrmin, Har-. vard Apparatus, South Natick, MA with air, supplemented Ž . with O 50% . Polyethylene catheters were inserted in a 2 carotid artery and jugular vein for measurement of arterial pressure and administration of drugs, respectively. Arterial and tracheal pressures were measured by strain gauges Ž . model 1270A, Hewlett Packard, Andover, MA , and heart Ž rate was measured by a cardiotachometer Coulburn Instru-. ments, Allentown, PA triggered by the arterial pressure Ž pulse. Heart rate, arterial pressure and nerve discharge see . Ž below were recorded by a thermal recorder model . MT95000, Astro-Med, West Warwick, RI .
Vagal afferent impulses were recorded from fine slips of the left cervical vagus. Sympathetic afferent impulses were recorded from fine slips of the left stellate nerve dissected from the stellate ganglion. Nerves were covered with mineral oil and placed on a silver electrode. Impulses Ž were amplified model P511, Grass Instruments, Quincy, . Ž MA , displayed on an oscilloscope model 450, Gould . Instrument Systems, Valley View, OH , and fed into a rate Ž . meter Frederick Haer, Brunswick, ME whose window discriminators were set to accept potentials of a particular amplitude. Impulses were counted by ratemeter in 1-s bins. Bundles that had one, or at most two, easily distinguishable active fibers were used. We studied only spontaneously active fibers which had receptive fields in the heart that could be located precisely.
Chemosensitivity of an ending was tested by intravenous injection and epicardial application of capsaicin to Ž . the surface of the heart. Capsaicin 1 mgrml was dissolved in saline containing 10% ethanol and 1% Tween-80 and then diluted to the final concentrations with saline. Capsaicin was injected intravenously in doses of 1.6-3.2 Ž . nmol 0.1-0.2 ml of 50 mgrml solution and then, if the Ž . fiber was activated, capsaicin 0.16-16 nmol in 10 ml was applied directly to surface of the heart with a small circle of filter paper 3 mm in diameter to determine the receptive field. We considered the fiber to be activated when its activity increased by more than 25% above the baseline. Once the receptive field was localized, bradykinin Ž . Ž 0.1-10 nmol in 10 ml of saline , H O 1.5-30 mmol in 2 2 . Ž 10 ml of saline , and X q XO mixture 1 mmol and 0.03 . mU respectively in 10 ml of saline were applied to the epicardial surface encompassing the receptive field with filter paper for 30 s. A period of 30 s is sufficient for the afferent endings to achieve a maximum response to the w x chemical application 13 . All chemicals were tested in random order. Applications of capsaicin vehicle or saline Ž . alone were tested and found to have no effect on fiber activity.
After each application, the paper was removed and the surface of the heart was washed with warm saline. Intervals of 10-15 min were allowed between applications. If the fiber was activated with capsaicin, bradykinin, H O , 2 2 andror xanthinerxanthine oxidase, applications of the effective doses were repeated 5 min after intravenous Ž . administration of either capsazepine 200 mgrkg, i.v. or Ž . ruthenium red 780 mgrkg, i.v. . In control experiments, applications of effective doses of the drugs were repeated after administration of capsazepine or ruthenium red vehicle to assure that the response was reproducible.
Ž . Capsazepine 5 mg was dissolved in 0.133 ml of DMSO and then diluted with saline containing 10% of ethanol and 1% of Tween-80 to a concentration of 200 mgrml. Ruthenium red was prepared at the concentration 780 mgrml in saline. Administration of capsazepine vehicle or saline had no effect on fiber responses to chemical agonists. Capsazepine was obtained from Research Bio-Ž . chemicals International Natick, MA ; all other drugs were Ž . obtained from Sigma Chemical St. Louis, MO .
Experiments performed by Franco-Cereceda and cow x authors 18,19 in the isolated perfused guinea-pig heart, showed that capsazepine inhibited the release of calcitonin gene-related peptide from cardiac sensory nerves caused by a decrease in pH of the perfusion solution. They suggested that acidosis may cause the release of some endogenous ligand for the capsaicin receptor. We considered the possibility that the pH of our H O solution and tions of 10 ml of HCl solutions with pH in the range of 3.0-7.0. We also considered the possibility that capsazepine and ruthenium red possess free radical scavenging properties that can explain their inhibitory effect on H O and X q 2 2 XO-induced responses of cardiac afferents. For this reason, we tested the ability of capsazepine and ruthenium red to Ž . inhibit the reduction of nitroblue tetrazolium NBT medi-Ž ated by superoxide anion in non-enzymatic phenazine . methosulfate-NADH reactions in vitro and compared it with free radical scavenging properties of superoxide dis-Ž . w x mutase SOD 20 . The reaction mixture contained 1 mM of NBT, 30 mM of phenazine methosulfate and 156 mM of NADH in 0.1 M phosphate buffer, pH 7.4. Reduction of NBT was measured by a Milton-Roy spectrophotometer as a change in absorbency at 560 nm during 5 min either in the presence or in the absence of increasing concentrations of capsazepine, ruthenium red, or SOD.
Reported values are means " s.e.m. The firing rate of afferent fibers was calculated as the average number of Ž . impulses per second imprs over a period of 10 s of maximal activity during 60 s immediately before and during the 60 s after drug application. Threshold doses of capsaicin, H O , and bradykinin necessary to activate the 2 2 endings were calculated from the dose-response curves using least-squares regression analysis. Differences among treatments were determined by analysis of variance for repeated measures, and differences between means were isolated by the Bonferroni correction for multiple t-tests. Statistical significance was accepted at P -0.05.
These investigative procedures conform with the Guide for the Care and Use of Laboratory Animals published by Ž the US National Institutes of Health NIH Publication No.
. 85-23, revised 1985 .
Results
Effect of capsazepine and ruthenium red on the responses of cardiac Õagal afferent fibers to chemical agonists
In 26 rats we obtained recordings from a total of 41 vagal afferent fibers with receptive fields in various areas of the heart. Twenty four of these endings were capsaicin Ž . sensitive 1.6-16.0 nmol . Each of the capsaicin-sensitive fibers was also activated by epicardial application of Ž . bradykinin 1.0-10.0 nmol . Endings that were not cap- . mmol as well. Only the endings that responded to all three Ž . agonists capsaicin, H O , and bradykinin were used in 2 2 this study. These chemosensitive endings did not exhibit characteristics of mechanosensitive endings, such as a cardiac or respiratory rhythm or a responsiveness to changes in cardiac hemodynamics. The receptive fields of these fibers were located: 5 in the right atrium, 3 in the left atrium and 9 in the left ventricle. The average maximum baseline activity for these vagal afferent fibers was 1.1 " 0.2 imprs. Epicardial capsaicin application evoked an increase in fiber activity with a latency of 4-6 s; the threshold dose of capsaicin was 0.54 " 0.23 nmol as determined by regression analysis. H O increased the firing 2 2 rate of the vagal fibers with a latency of 2-6 s at a threshold dose of 3.47 " 0.81 mmol. Application of bradykinin stimulated vagal afferent endings at a threshold dose of 0.65 " 0.3 nmol with a latency of 4-8 s. Fig. 1 illustrates the response of a representative vagal afferent fiber from the left ventricle to epicardial application of Ž . capsaicin, H O , and bradykinin left panels . The dose- 2 2 Ž . response effects of epicardial applications of capsaicin A , Ž . Ž . H O B , and bradykinin C on cardiac vagal afferent 2 2 activity are illustrated in Fig. 2 .
Administration of capsazepine had no effect on the baseline activity of the vagal endings which averaged 1.1 " 0.2 before and 1.1 " 0.3 imprs 5 min after capsazepine administration. Capsazepine completely abolished the response of vagal afferent fibers to capsaicin and H O 2 2 and had no effect on the afferent responses to bradykinin Ž . Fig. 1, Fig. 2 . Five cardiac vagal endings were tested with epicardial applications of the xanthinerxanthine oxidase mixture; activity of their afferent fibers in response to xanthinerxanthine oxidase increased from 0.6 " 0.3 to Ž . 3.4 " 1.3 imprs P -0.01 The afferent response to xanthinerxanthine oxidase also was abolished by capsazepine Ž . Fig. 3 . Applications of capsaicin, bradykinin, H O or 2 2 X q XO after administration of capsazepine vehicle induced afferent responses that did not differ from responses Ž . at the same doses before vehicle administration Table 1 . Table 2 presents the data on the effect of ruthenium red on the responses of cardiac vagal chemosensitive afferents to epicardial applications of chemicals agonists. Predictably, administration of this capsaicin antagonist inhib- ited activation of vagal afferent fibers by capsaicin. Responses to epicardial applications of H O and X q XO 2 2 were also completely abolished after administration of ruthenium red. No significant effects on the responses of vagal afferents to bradykinin were observed after administration of this inhibitor. 
Effect of capsazepine on the responses of cardiac sympathetic afferent fibers to chemical agonists
Ž
. bradykinin left panels . Sensitivity to each of these chemical stimuli was markedly greater for the sympathetic afferent fibers than for vagal afferents. The sympathetic afferent fibers responded to a threshold dose of capsaicin of 0.10 " 0.08 nmol with a latency of 1 s or less. H O 2 2 increased the firing rate of these fibers with a latency of 1-2 s at a threshold dose of 1.51 " 0.22 mmol. The threshold dose for bradykinin was 0.05 " 0.02 nmol with a similar short latency. The higher sensitivity and shorter latency of response of sympathetic afferents to epicardial application of these drugs may be due to the more superficial location of the endings in the myocardium as comw x pared to the vagal afferents 21 . Nine sympathetic afferent fibers were tested with epicardial applications of xanthinerxanthine oxidase. All these fibers were sensitive to xanthinerxanthine oxidase, and their discharge increased Ž .Ž . from 3.3 " 1.2 to 13.7 " 3.0 imprs P -0.01 Fig. 3 . Fig. 5 illustrates dose-response effect of the sympathetic cardiac fibers to epicardial applications of capsaicin Ž .
Ž . Ž . A , H O B , and bradykinin C before and after admin- 2 2 istration of capsazepine. The responses of sympathetic afferent fibers to capsaicin and H O were abolished after 2 2 Ž . capsazepine administration Fig. 4, Fig. 5A ,B . The response of the sympathetic afferents to xanthinerxanthine oxidase after capsazepine administration also was signifi-Ž . cantly inhibited Fig. 3 . Capsazepine had no effect on the response of cardiac sympathetic afferents to bradykinin Ž . Fig. 4, Fig. 5C .
Administration of ruthenium red inhibited activation of sympathetic afferent fibers by capsaicin. Responses to epicardial applications of H O and X q XO were also 2 2 completely abolished after administration of ruthenium red. No significant effects on the responses of the sympathetic afferents to bradykinin were observed after administration of this inhibitor. Table 3 Urml. Capsazepine and ruthenium red in the dose range of 0.01-100 mM had no effect on the NBT reaction suggesting that these drugs do not possess free radical scavenging activity.
Effect of capsazepine on the responses of Õagal and sympathetic afferent fibers to epicardial HCl
Free radical scaÕenging properties of capsazepine and ruthenium red
Discussion
The results of these experiments provide evidence that blockade of capsaicin receptors with either capsazepine or ruthenium red inhibits activation of both vagal and sympathetic cardiac afferent fibers by free oxygen radicals. The fact that these agents did not affect the afferent response to bradykinin suggests that this effect of the blockers was w x specific for capsaicin receptors 17 . w x Recently, Franco-Cereceda and co-authors 18, 19 showed in the isolated perfused guinea-pig heart that a decrease in pH of the perfusion solution caused the release of calcitonin gene-related peptide from the sensory nerves; capsazepine inhibited this effect. They suggested that acidosis may cause the release of some endogenous ligand for the capsaicin receptor. We considered the possibility that the pH of our H O solution and a X q XO mixture was 2 2 responsible for activation of the afferents when these chemicals were applied; and thus, the effect of capsazepine to inhibit these responses was due to its ability to inhibit pH-induced activation of the sensory endings rather than free-radical induced activation. The pH of 30 mM H O 2 2 Ž solution the highest concentration we used for epicardial . applications is 5.8, and that of X q XO mixture is 7.2. In our experiments we found that epicardial applications of 10 ml of HCl solutions with pH in the range of 5.0-7.0 did not activate vagal or sympathetic afferent fibers. These findings are in accordance with the data of Uchida and w x Murao 22 which showed that the threshold pH for activation of cardiac sympathetic fibers with epicardial application of HCl was 3.85-3.20. Furthermore, we have demonstrated previously that antioxidants completely prevent activation of the cardiac vagal afferent fibers in response to either H O or X q XO, suggesting that this activation 2 2 w x was indeed mediated by oxygen free radicals 13 . Thus, it is not likely that changes in pH mediated the effects of oxygen free radicals in our study.
We also considered the possibility that capsazepine and ruthenium red possess free radical scavenging properties that can explain their inhibitory effect on H O and X q 2 2 XO-induced responses of cardiac afferents. We found that capsazepine and ruthenium red have no effect on the reduction of NBT mediated by formation of superoxide anion in vitro. We concluded that observed effects of capsazepine and ruthenium red could not be explained by their free radical scavenging activity, but were due to its capsaicin receptor inhibiting properties.
We and other studies have shown that free oxygen radicals can stimulate chemosensitive sensory nerve endw x ings in the heart 13-15 producing reflex responses mediw x ated by these afferents 16 , but the mechanism of their effect on afferent endings remains uncertain. It is possible that oxygen radicals may cause the release of an yet unknown endogenous ligand for the capsaicin receptor, w x similar to that proposed by Franco-Cereceda et al. 18 . Alternatively, it is known that free oxygen radicals are able to change properties of membrane-bound integral proteins w x 23,24 , probably by affecting the protein tertiary structure and membrane lipid viscosity. It is possible that the capsaicin receptor is the one of the proteins that is modulated by free oxygen radicals thus mediating their action on afferent fibers. The capsaicin receptor comprises a non-selective cationic channel which evokes an inward depolarizing current upon binding with the agonist. One can postulate that free oxygen radicals cause a conformational change of the integral protein of the receptor and thus increase permeability of the cationic channel. Binding of the receptor with specific inhibitor, capsazepine, prevents this effect probably by stabilization of its tertiary structure. The molecular mechanism of the free oxygen radical interaction with the capsaicin receptor requires further investigation.
The functional role of the capsaicin receptor has rew x mained a mystery since its discovery 25 . Our results suggest a possible role for the capsaicin receptor in mediating cardiac reflex responses to oxygen radicals. Recently we demonstrated that reflex changes in renal sympathetic nerve activity after prolonged ischemia of the rat heart and during reperfusion are mediated by activation of vagal and sympathetic afferent endings by oxygen-derived free radicals and can be abolished with the antioxidant, desferoxw x amine 26 . In the light of these results it is possible that the capsaicin receptor may play an important role in the disturbances of autonomic regulation during ischemia and reperfusion and in other numerous pathological states associated with the increased formation of oxygen-derived free radicals.
